Biofrontera announced the appointment of George Jones as chief commercial officer, starting August 25. In this role, Jones will oversee the company’s commercial functions, including sales, marketing, and market access. He will report directly to CEO Hermann Luebbert.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BFRI:
- Biofrontera, Inc. (BFRI) Q2 Earnings Cheat Sheet
- Biofrontera Inc. files to sell 13.6M shares of common stock for holders
- Biofrontera Finalizes Acquisition of U.S. Ameluz Rights
- Biofrontera Restructures U.S. Rights with $11M Investment
- Biofrontera Inc. price target raised to $10 from $8 at Roth Capital